REVIEW COVID-19 (SARS-COV-2) AND MEDICINAL PLANTS – LITERATURE

Detalhes bibliográficos
Autor(a) principal: Cassaro, Luís Antônio
Data de Publicação: 2022
Outros Autores: Moretto, Lorena de Fátima, Batista, Aline Cristiane Cechinel Assing, Santos, Isabela Carvalho dos, Trevisani, Adriane Cordeiro, Belettini, Salviano Tramontin, Zardeto, Giuliana, Rey, Laisa Marina Rosa, Boleta-Ceranto, Daniela de Cassia Faglioni, Mendonça, Juliana Aparecida, Cogo, Juliana, Alexandre, Monica Micheli, Gazin, Zilda Cristiani, Lourenço, Emerson Luiz Botelho, Barbosa, Lidiane Nunes, Gonçalves, Daniela Dib
Tipo de documento: Artigo
Idioma: por
Título da fonte: Arquivos de Ciências da Saúde da UNIPAR (Online)
Texto Completo: https://revistas.unipar.br/index.php/saude/article/view/9028
Resumo: In December 2019, a new coronavirus originating from the city of Wuhan in China started an epidemic that brought many countries into chaos and despair. SARS-CoV-2, as identified, gave rise to the severe acute respiratory syndrome called COVID-19. Its transmission happens through droplets of saliva, hand or contaminated surfaces. Since its discovery, COVID-19 has led many to death, therefore, researchers from around the world have joined efforts to develop strategies to contain the virus. In this race, drugs such as Chloroquine and Hydroxychloroquine have become possible options for showing an antiviral effect, however, studies contest their efficiency, generating uncertainties. Therefore, other alternatives have been investigated in this context, and the study of medicinal plants has been the target of research for the treatment of COVID-19 in search of bioactive natural products that can exert an antiviral action. The study aimed to analyze the published literature on COVID-19 (SARS-CoV-2) and its relationship with medicinal plants. Bibliographical survey. So far, no specific treatment against the disease has been found, only supportive, with drugs that aim to improve the individual's immune system and ensure that the virus does not replicate, for example, there are options such as chloroquine, hydroxychloroquine, remdesivir and convalescent plasma. On the other hand, studies have revealed that medicinal plants such as garlic, among others, showed efficiency in modulating proteins with a view to preventing viral replication and improving immunity against COVID-19. So far, there are no drugs that are completely safe and have been shown to have activity against the new coronavirus (SARS-CoV-2). However, medicinal plants can contribute to the development of specific therapies against SARS-CoV-2 in a safe and effective way.
id UNIPAR-1_22d8bf318c173bebddf626a215699744
oai_identifier_str oai:ojs2.revistas.unipar.br:article/9028
network_acronym_str UNIPAR-1
network_name_str Arquivos de Ciências da Saúde da UNIPAR (Online)
repository_id_str
spelling REVIEW COVID-19 (SARS-COV-2) AND MEDICINAL PLANTS – LITERATUREIn December 2019, a new coronavirus originating from the city of Wuhan in China started an epidemic that brought many countries into chaos and despair. SARS-CoV-2, as identified, gave rise to the severe acute respiratory syndrome called COVID-19. Its transmission happens through droplets of saliva, hand or contaminated surfaces. Since its discovery, COVID-19 has led many to death, therefore, researchers from around the world have joined efforts to develop strategies to contain the virus. In this race, drugs such as Chloroquine and Hydroxychloroquine have become possible options for showing an antiviral effect, however, studies contest their efficiency, generating uncertainties. Therefore, other alternatives have been investigated in this context, and the study of medicinal plants has been the target of research for the treatment of COVID-19 in search of bioactive natural products that can exert an antiviral action. The study aimed to analyze the published literature on COVID-19 (SARS-CoV-2) and its relationship with medicinal plants. Bibliographical survey. So far, no specific treatment against the disease has been found, only supportive, with drugs that aim to improve the individual's immune system and ensure that the virus does not replicate, for example, there are options such as chloroquine, hydroxychloroquine, remdesivir and convalescent plasma. On the other hand, studies have revealed that medicinal plants such as garlic, among others, showed efficiency in modulating proteins with a view to preventing viral replication and improving immunity against COVID-19. So far, there are no drugs that are completely safe and have been shown to have activity against the new coronavirus (SARS-CoV-2). However, medicinal plants can contribute to the development of specific therapies against SARS-CoV-2 in a safe and effective way.UNIPAR2022-12-20info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://revistas.unipar.br/index.php/saude/article/view/902810.25110/arqsaude.v26i3.2022.9028Arquivos de Ciências da Saúde da UNIPAR; v. 26 n. 3 (2022)1982-114X10.25110/arqsaude.v26i3.2022reponame:Arquivos de Ciências da Saúde da UNIPAR (Online)instname:Universidade Paranaense (UNIPAR)instacron:UNIPARporhttps://revistas.unipar.br/index.php/saude/article/view/9028/4446Copyright (c) 2022 Arquivos de Ciências da Saúde da UNIPARinfo:eu-repo/semantics/openAccessCassaro, Luís AntônioMoretto, Lorena de FátimaBatista, Aline Cristiane Cechinel AssingSantos, Isabela Carvalho dosTrevisani, Adriane CordeiroBelettini, Salviano TramontinZardeto, GiulianaRey, Laisa Marina RosaBoleta-Ceranto, Daniela de Cassia FaglioniMendonça, Juliana AparecidaCogo, JulianaAlexandre, Monica MicheliGazin, Zilda CristianiLourenço, Emerson Luiz BotelhoBarbosa, Lidiane NunesGonçalves, Daniela Dib2022-12-20T07:55:13Zoai:ojs2.revistas.unipar.br:article/9028Revistahttp://revistas.unipar.br/index.php/saudehttp://revistas.unipar.br/saude/oai||cedic@unipar.br|| arqsaude@unipar.br1982-114X1415-076Xopendoar:2022-12-20T07:55:13Arquivos de Ciências da Saúde da UNIPAR (Online) - Universidade Paranaense (UNIPAR)false
dc.title.none.fl_str_mv REVIEW COVID-19 (SARS-COV-2) AND MEDICINAL PLANTS – LITERATURE
title REVIEW COVID-19 (SARS-COV-2) AND MEDICINAL PLANTS – LITERATURE
spellingShingle REVIEW COVID-19 (SARS-COV-2) AND MEDICINAL PLANTS – LITERATURE
Cassaro, Luís Antônio
title_short REVIEW COVID-19 (SARS-COV-2) AND MEDICINAL PLANTS – LITERATURE
title_full REVIEW COVID-19 (SARS-COV-2) AND MEDICINAL PLANTS – LITERATURE
title_fullStr REVIEW COVID-19 (SARS-COV-2) AND MEDICINAL PLANTS – LITERATURE
title_full_unstemmed REVIEW COVID-19 (SARS-COV-2) AND MEDICINAL PLANTS – LITERATURE
title_sort REVIEW COVID-19 (SARS-COV-2) AND MEDICINAL PLANTS – LITERATURE
author Cassaro, Luís Antônio
author_facet Cassaro, Luís Antônio
Moretto, Lorena de Fátima
Batista, Aline Cristiane Cechinel Assing
Santos, Isabela Carvalho dos
Trevisani, Adriane Cordeiro
Belettini, Salviano Tramontin
Zardeto, Giuliana
Rey, Laisa Marina Rosa
Boleta-Ceranto, Daniela de Cassia Faglioni
Mendonça, Juliana Aparecida
Cogo, Juliana
Alexandre, Monica Micheli
Gazin, Zilda Cristiani
Lourenço, Emerson Luiz Botelho
Barbosa, Lidiane Nunes
Gonçalves, Daniela Dib
author_role author
author2 Moretto, Lorena de Fátima
Batista, Aline Cristiane Cechinel Assing
Santos, Isabela Carvalho dos
Trevisani, Adriane Cordeiro
Belettini, Salviano Tramontin
Zardeto, Giuliana
Rey, Laisa Marina Rosa
Boleta-Ceranto, Daniela de Cassia Faglioni
Mendonça, Juliana Aparecida
Cogo, Juliana
Alexandre, Monica Micheli
Gazin, Zilda Cristiani
Lourenço, Emerson Luiz Botelho
Barbosa, Lidiane Nunes
Gonçalves, Daniela Dib
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Cassaro, Luís Antônio
Moretto, Lorena de Fátima
Batista, Aline Cristiane Cechinel Assing
Santos, Isabela Carvalho dos
Trevisani, Adriane Cordeiro
Belettini, Salviano Tramontin
Zardeto, Giuliana
Rey, Laisa Marina Rosa
Boleta-Ceranto, Daniela de Cassia Faglioni
Mendonça, Juliana Aparecida
Cogo, Juliana
Alexandre, Monica Micheli
Gazin, Zilda Cristiani
Lourenço, Emerson Luiz Botelho
Barbosa, Lidiane Nunes
Gonçalves, Daniela Dib
description In December 2019, a new coronavirus originating from the city of Wuhan in China started an epidemic that brought many countries into chaos and despair. SARS-CoV-2, as identified, gave rise to the severe acute respiratory syndrome called COVID-19. Its transmission happens through droplets of saliva, hand or contaminated surfaces. Since its discovery, COVID-19 has led many to death, therefore, researchers from around the world have joined efforts to develop strategies to contain the virus. In this race, drugs such as Chloroquine and Hydroxychloroquine have become possible options for showing an antiviral effect, however, studies contest their efficiency, generating uncertainties. Therefore, other alternatives have been investigated in this context, and the study of medicinal plants has been the target of research for the treatment of COVID-19 in search of bioactive natural products that can exert an antiviral action. The study aimed to analyze the published literature on COVID-19 (SARS-CoV-2) and its relationship with medicinal plants. Bibliographical survey. So far, no specific treatment against the disease has been found, only supportive, with drugs that aim to improve the individual's immune system and ensure that the virus does not replicate, for example, there are options such as chloroquine, hydroxychloroquine, remdesivir and convalescent plasma. On the other hand, studies have revealed that medicinal plants such as garlic, among others, showed efficiency in modulating proteins with a view to preventing viral replication and improving immunity against COVID-19. So far, there are no drugs that are completely safe and have been shown to have activity against the new coronavirus (SARS-CoV-2). However, medicinal plants can contribute to the development of specific therapies against SARS-CoV-2 in a safe and effective way.
publishDate 2022
dc.date.none.fl_str_mv 2022-12-20
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://revistas.unipar.br/index.php/saude/article/view/9028
10.25110/arqsaude.v26i3.2022.9028
url https://revistas.unipar.br/index.php/saude/article/view/9028
identifier_str_mv 10.25110/arqsaude.v26i3.2022.9028
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://revistas.unipar.br/index.php/saude/article/view/9028/4446
dc.rights.driver.fl_str_mv Copyright (c) 2022 Arquivos de Ciências da Saúde da UNIPAR
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2022 Arquivos de Ciências da Saúde da UNIPAR
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv UNIPAR
publisher.none.fl_str_mv UNIPAR
dc.source.none.fl_str_mv Arquivos de Ciências da Saúde da UNIPAR; v. 26 n. 3 (2022)
1982-114X
10.25110/arqsaude.v26i3.2022
reponame:Arquivos de Ciências da Saúde da UNIPAR (Online)
instname:Universidade Paranaense (UNIPAR)
instacron:UNIPAR
instname_str Universidade Paranaense (UNIPAR)
instacron_str UNIPAR
institution UNIPAR
reponame_str Arquivos de Ciências da Saúde da UNIPAR (Online)
collection Arquivos de Ciências da Saúde da UNIPAR (Online)
repository.name.fl_str_mv Arquivos de Ciências da Saúde da UNIPAR (Online) - Universidade Paranaense (UNIPAR)
repository.mail.fl_str_mv ||cedic@unipar.br|| arqsaude@unipar.br
_version_ 1800218855873708032